Comparison Chart BioNTech SE Wiener Boerse
Stocks
BNTX
US09075V1026
Biotechnology & Medical Research
|
End-of-day quote
Wiener Boerse
2026-09-28
|
5-day change | 1st Jan Change | ||
| 86.35 EUR | -0.35% |
|
+3.17% | +6.41% |
| 09-11 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIONTECH SE | Bio Therapeutic Drugs | -0.35% | +3.17% | +6.41% | +3.29% | -69.49% | 24.75B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BNTX Stock
- BNTX Stock
- Charts BioNTech SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
